Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

# Structures of highly flexible intracellular domain of human α7 nicotinic acetylcholine receptor

## Abstract

The intracellular domain (ICD) of Cys-loop receptors mediates diverse functions. To date, no structure of a full-length ICD is available due to challenges stemming from its dynamic nature. Here, combining nuclear magnetic resonance (NMR) and electron spin resonance experiments with Rosetta computations, we determine full-length ICD structures of the human α7 nicotinic acetylcholine receptor in a resting state. We show that ~57% of the ICD residues are in highly flexible regions, primarily in a large loop (loop L) with the most mobile segment spanning ~50 Å from the central channel axis. Loop L is anchored onto the MA helix and virtually forms two smaller loops, thereby increasing its stability. Previously known motifs for cytoplasmic binding, regulation, and signaling are found in both the helices and disordered flexible regions, supporting the essential role of the ICD conformational plasticity in orchestrating a broad range of biological processes.

## Introduction

Eukaryotic pentameric ligand-gated ion channels (pLGICs), often called Cys-loop receptors, share a common tripartite structural architecture. Each receptor consists of an extracellular domain (ECD) containing agonist-binding sites, a transmembrane domain (TMD) enclosing a channel gate, and an intracellular domain (ICD) that refers to the regions connecting the TMD helices TM3 and TM4. Compared to the ECD and TMD, the ICD is involved in much more divergent functions. It plays a critical role in receptors’ trafficking, localization, and assembly1. The ICD also affects channel conductance and desensitization2,3. Furthermore, the ICD mediates receptor-receptor interactions4 and interactions with intracellular proteins that regulate diverse downstream signaling pathways5. It has been recognized as a potential target for drug design6.

Despite its important functional roles, the ICD of Cys-loop receptors lacks comprehensive structure information. Recent advances in the field of structural biology have considerably increased the number of Cys-loop receptor structures, but none included a complete ICD structure. The structurally characterized Cys-loop receptors were often engineered by replacing the native ICD with shorter peptides to augment structure quality7. Even without engineering, the ICD structures could at best be partially determined due to inherent structural flexibility in this domain8,9. Thus, neither X-ray crystallography nor cryo-EM are suited for resolving full-length structures of flexible ICDs.

The launch of AlphaFold210 and RoseTTAFold11 has revolutionized predictions of protein 3D structures with excellent accuracy. These deep-learning neural network computing software can predict structures of many proteins even without homologs of known structure. However, the prediction confidence depends heavily on the availability of similar local patterns (in the absence of homologs) or well-defined structural packing. In the case of the ICD of Cys-loop receptors, no homolog of known structures is available, and the domain is partly unstructured rather than efficiently packed with few obvious patterns. These lead to predictions that fall in the “very low” confidence category (https://alphafold.ebi.ac.uk/entry/P36544). Thus, new experimental data are critical to resolve structures of this domain.

In this work, we combine experimental structure restraints from nuclear magnetic resonance (NMR) and electron spin resonance (ESR) spectroscopy with Rosetta computations and determine the full-length ICD structures of the human α7 nicotinic acetylcholine receptor (α7nAChR), a major subtype of neuronal nAChRs in the brain. NMR and ESR spectroscopy are well established for providing structural information on flexible or even disordered proteins12. The α7nAChR is involved in a wide range of physiological and pathological processes13. It is a potential target for the treatment of addiction, Alzheimer’s disease, schizophrenia, inflammation and pain, and other disorders13,14. It is noteworthy that the α7nAChR’s involvement in various processes is mediated not only by its well-characterized ionotropic function, but also by its increasingly recognized metabotropic function5. The ICD plays a central role in networking with protein partners associated with diverse downstream signaling pathways5. Our α7nAChR ICD structures will facilitate the understanding of these signaling pathways and the design of strategies to manipulate interaction networks for the advancement of therapeutic treatment.

## Results

### α7nAChR constructs suitable for NMR structural investigation of the ICD

A full-length human α7nAChR15,16 is well suited for ESR measurements but is too large to perform structural analysis using solution NMR. Thus, for NMR structural determinations, we designed an α7nAChR construct, named TMD + ICD, that encompasses the TMD and ICD with 264 residues (L209-V472) (Supplementary Fig. 1). Although the ICD is the focus of our investigation, the inclusion of the TMD in the construct facilitates a pentameric assembly of the ICD. Indeed, the TMD + ICD forms not only pentamers (Supplementary Fig. 2), but also functional channels as observed previously with the TMD alone17. The TMD + ICD channels can be activated by ivermectin and potentiated by the α7nAChR-specific positive allosteric modulator (PAM) PNU-120596 in a concentration dependent manner (Fig. 1a, b). Furthermore, the TMD + ICD in micelles shows similar binding affinities to PAMs as the full-length α7nAChR (Supplementary Fig. 2). The binding of the intracellular scaffold protein PICK116 is virtually the same in the TMD + ICD and the full-length α7nAChR (Supplementary Fig. 2). These data support the functional and pharmacological relevance of the TMD + ICD for structural studies.

The ICD is soluble, but the TMD requires membrane mimetics for stabilization. After extensive screening and testing, we have identified LDAO micelles and asolectin nanodiscs as the mimetics, in which the TMD + ICD is stable and exhibits essentially the same folding, as evidenced by nearly identical NMR chemical shifts (Δδ < 0.07 ppm) of the ICD residues (Fig. 1c). However, fewer residues with broader peaks appeared in NMR spectra of nanodisc samples at a range of temperatures (Supplementary Fig. 3) due to the larger size and slower diffusion of nanodiscs in solution NMR. Thus, the micelle mimetic is a better choice for the TMD + ICD based on a combined consideration of protein stability, folding, pharmacological properties, and quality information from NMR spectroscopy.

### TMD+ICD structure determination and a glance at the ICD structures

The pentameric structures of the TMD + ICD (PDBID: 7RPM) were determined using an iterative protocol (the “Methods” section and Supplementary Fig. 4) with structure restraints derived from NMR and ESR experiments (Supplementary Figs. 510; Supplementary Tables 1), which include NMR chemical shifts, nuclear Overhauser effects (NOEs), and residual dipolar couplings (RDCs) for generating secondary structures and Rosetta fragments18, distance restraints derived from NOEs and paramagnetic relaxation enhancement (PRE) for determining tertiary structures, and quaternary distance restraints derived from the inter-subunit 19F PREs19 and 1H PREs20 NMR or from double electron-electron resonance (DEER) ESR21. These experimental restraints were integrated into Rosetta22 to generate an ensemble of pentameric TMD + ICD structures through iterative calculations (Supplementary Fig. 4). The final structures of the TMD + ICD pentamer were validated by an independent set of restraints that had not been used in the structure calculations (see the “Methods” section). The number of various experimental restraints used for structure determination and structure statistics are summarized in Supplementary Tables 1 and 2, respectively. The TMD + ICD structure resembles the available corresponding regions (the TMD and MX/MA helices) in the structures of apo α7nAChR (PDBID: 7EKI)23 and an antagonist-bound α7nAChR (PDBID: 7KOO)7 (Supplementary Fig. 11).

The α7nAChR TMD + ICD structure offers a glimpse of a 3D shape of the entire ICD (Fig. 2a–c), which has a height of ~60 Å (measured between Cα atoms of H296 and G402) and a maximum radius of ~50 Å (measured from the Q336 Cα atom to the center of the pore). Each ICD features four regions: a short post-TM3 loop (H296-K307), a MX α-helix (W308-L321) lying nearly parallel to the membrane surface, a large loop L (R322-D408) (Fig. 2d) that could not be determined by cryo-EM7,23, and a long MA α-helix (P409-C443) that merges with the TM4 helix. A stereo image showing the 15 lowest-energy structures of the TMD + ICD is provided in Supplementary Fig. 12.

Loop L harbors three short helices (h1, P326-K330; h2, K338-R340; and h3, N361-F367) (Fig. 2b). The h3 α-helix in the middle of loop L is anchored onto the MA helix through electrostatic and Van der Waals interactions (R368-E430; F367-R426), dividing loop L into two smaller loops with a “B” shape and thereby increasing the loop stability24. Most residues of loop L exhibit faster motion as indicated by their higher NMR signal intensities (peak height) than residues in the MX and MA helices (Fig. 2d). The region containing the h1 α-helix and the h2 310-helix shows particularly higher mobility as evidenced in the substantially higher NMR intensities, consistent with their positions being most distal from the MA helices (Fig. 2a). The distinctly different dynamics of residues near h3 compared to the rest of the residues in loop L is also evidenced in measurements of backbone dynamics as quantified by NMR 15N R1 and R2 relaxation rates and 15N-(1H)NOE (Supplementary Fig. 13). Overall, loop L displays substantial disordered regions and flexibility that may be required to accommodate different functions.

### Major interactions stabilizing the ICD

There is a high fraction of charged residues (18 pairs) in the ICD that distribute unevenly and result in regions with net positive or negative charges (Fig. 3a). The upper region of the ICD has net positive charges, which can interact with the negatively charged inner membrane leaflet. The bottom ICD region is rich with negative-charge residues that potentially bind opposite-charge molecular partners. Charged residues form salt bridges that stabilize the secondary structure (R325-E328; D329-R332; D410-K413), tertiary structure, and quaternary structure. R310-E437 (Fig. 3b) and R368-E430 (Fig. 3c) anchor the MX and h3 helices, respectively, to the MA helix. Salt bridges between adjacent MA helices (E417-R419 and R424-D429) (Fig. 3d) support quaternary structures that are also observed in the partially resolved antagonist-bound α7nAChR7. Mutating these residues affected α7nAChR expression2.

Hydrogen bonding is a dominant force in forming helices, but also exists in forming turns in disordered regions (Fig. 3e) or even supporting quaternary structures (Fig. 3f). These hydrogen bonds have short donor-acceptor distances (<3.2 Å), but their hydrogen atoms often have a donor–acceptor alignment angle of 20˚<θ < 45˚ so that the hydrogen bond strength is weakened compared to that found in the well-structured helices25. This type of weak hydrogen bond is better suited for setting dynamic equilibrium among interconvertible conformations in disordered proteins or flexible regions26.

Despite their lower abundance, hydrophobic interactions exist in disordered loop regions, such as shown in Fig. 3g. Hydrophobic interactions are major contributors to the packing of the bundle of MA helices, especially at the bottom of the ICD.

### Sequence and structure motifs of the ICD

Motifs relevant to ICD functionality27 have been found in both structured and disordered regions. Here, using our full-length ICD structure, we attempt to link known sequence and structure motifs to some of their functional engagements. The linkage will help design rigorous studies to further understand the underlying structural bases of functional impacts.

The segment of [307KWTRVILL314] in the first half of the MX helix (Fig. 4) matches the classic mitogen-activated protein kinase (MAPK) docking motif (Kxxxx#x#, where # is a hydrophobic residue), which helps regulate specific interactions in the MAPK cascade27. The second half of the MX helix and two residues in the coil (322RM323) makes up the segment of [314LNWCAWFLRM323] (Fig. 4). This segment was found to directly interact with the c-terminus of the N-methyl-D-aspartate receptor (NMDAR) subtype 2 A (NR2A) subunit and participate in the formation of a α7nAChR-NMDAR complex involved in cue-induced reinstatement of nicotine seeking4. Upregulation of the α7nAChR-NMDAR complex was observed in brain tissue from rats chronically exposed to nicotine. Furthermore, the α7 peptide [314L-M323] was able to disrupt the complex and block reinstatement of nicotine seeking4. A lingering question is whether the peptide [314L-M323] is optimal for blocking reinstatement of nicotine seeking. Are the two coiled residues necessary for the peptide function? If yes, can the effect be further improved by adding two more positive charge residues (324KR325) in the coil? These questions remain to be answered by future studies.

The segment of [322RMKR325], identified by mutagenesis, binds Gq proteins to activate downstream signaling pathways involving phospholipase C and inositol triphosphate (IP3)-mediated intracellular calcium release5. Notably, in our ICD structure (Fig. 4), this disordered segment lies between two α helices (MX and h1). To some extent, this helix-coil-helix structural motif resembles GPCRs’ intracellular loops that bind Gq28. It will be interesting to determine in the future if the segment of [322RMKR325] selectively binds Gq or if it also binds to other G proteins.

The disordered segment [340RRCSLASVEMS350] (Fig. 4) contains a motif of 340R-346S to mediate protein kinase A (PKA)-type AGC kinase phosphorylation and a 343S-S350 motif to constitute a glycogen synthase kinase-3 (GSK3) phosphorylation site27. Note the conformational flexibility of these motifs and their exposure to potential binding partners. The ability to form electrostatic, hydrophobic, and hydrophilic interactions enable these motifs to recruit a diverse set of protein partners.

The segment of [362LLYIGF367] in the h3 helix (Fig. 4) was pinpointed by mutagenesis studies to be essential for the selective transport of α7nAChR to dendrites over axons in hippocampal neurons29, though the exact mechanism by which these residues regulate α7nAChR targeting was unclear. A tyrosine motif (YXXϕ) in this segment interacts with adaptor protein complexes for transmembrane protein transport and the interaction may facilitate dendritic localization of α7nAChR30. The α-helical structure of 362LLYIGF367 benefits the anchoring of the flexible loop to the MA helix (Fig. 2). Whether the α-helical structure is crucial for efficient interactions of the segment with the adaptor protein complexes to regulate α7nAChR targeting requires further investigation.

G382 and G386 form a weak hydrogen bond to fasten a helical turn comprised by a segment of [382GVVCG386] that exhibits a GXXXG motif (Fig. 4). The helical turn can be further stabilized by interactions of local residues (Supplementary Fig. 14). The GXXXG motif has been implicated in mediating transmembrane helix–helix association31, but its role in the ICD needs to be defined in the future.

Proline-rich motifs occur widely in eukaryotic proteins and serve for various functions in cellular processes32. The ICD contains 13 prolines and several proline-rich motifs, including tri-proline (354PPP356), PXP (377PTP379), and XPPX (404PP405) (Fig. 4). Several prolines (P306, P326, P409) at α-helix edges are expected to provide structural flexibility and mobility. Prolines in disordered regions are often exposed for covalent modification and signaling33.

### Pore conformation and ion permeation pathway

The pore profile of the α7nAChR TMD + ICD structures shows a non-conductive state (Fig. 5a), with the most constricted radius of ~1.6 Å at L248 (9′) in the TMD that is too small to pass a hydrated Na+ or Ca2+ ion (~3.6 or 4.1 Å radius, respectively). This hydrophobic gate at the 9′ position is conserved in apo23 and the antagonist-bound7 nAChRs (Supplementary Fig. 15), as well as in other resting-state cationic pLGICs8,34,35. The α7nAChR TMD pore profile resembles that of apo and the antagonist-bound α7nAChR but is distinctly different from those closed-pore profiles of desensitized nAChRs (Supplementary Fig. 15).

The pore widens near the TMD-ICD interface and reaches the maximum vestibule radius of ~9 Å before gradually shrinking into a small hydrophobic girdle, which consists of five hydrophobic residues (F425, I421, V418, I414, L411) along the MA helices with the smallest radius of ~1.5 Å at L411. Note that in the cryo-EM structures of α7nAChR, the small radius of this hydrophobic girdle in an antagonist-bound resting state increased only to a radius of ~3.7 Å in an active state7, suggesting a low probability for ions permeating through the hydrophobic girdle. Consistent with previous observations in α7nAChR and other homologous channels7,8, the α7nAChR TMD + ICD presents lateral portals formed by charged and polar residues at the subunit interfaces above the hydrophobic girdle, with a radius of ~3.6 Å (Fig. 5b) that could enlarge to a 4.8 Å radius to allow Na+ or Ca2+ ions to exit from the channel in an active α7nAChR (PDBID: 7KOX)7. The relevance of lateral portals to ion permeation has been documented previously by a mutagenesis and electrophysiology study2, in which mutations of α7nAChR lateral-portal residues caused either a decrease (Q428A, S431A, and E432A) or an increase (H298A and R424A) in channel currents in comparison to WT α7nAChR.

## Discussion

The α7nAChR TMD + ICD structure captures a complete picture of the ICD. The structured ICD regions resemble the MX and MA helices in the recently reported, partially resolved structures of apo23 and bungarotoxin-bound7 resting-state α7nAChRs (Supplementary Fig. 11). The ICD possesses ~57% disordered regions (turns or coils), higher than that in the ECD (~53%) and TMD (~14%) of α7nAChRs7,23. This finding supports the notion that disorder occurs preferentially on the intracellular side36. A more important contribution from the current study is the complete structural assessment of loop L in the ICD that could not be resolved by cryo-EM or X-ray crystallography. Our results show that loop L is not simply a structureless coil as predicted by AlphaFold210 (https://alphafold.ebi.ac.uk/entry/P36544), albeit in fairness the prediction for this region is flagged as falling in the “very low” confidence category, likely due to the lack of homologs of known structures, few local patterns corresponding to existing structures, and little sidechain packing information from semi-disordered regions. Experimental structures for domains like loop L should provide valuable training data sets to improve deep learning-based predictions for intrinsically disordered proteins or regions in general.

Our NMR data suggest that most residues in loop L experience faster motion and higher flexibility than those of well-structured long helices, as evidenced in their higher NMR peak intensities (Fig. 2d) and negative values of 15N-(1H) heteronuclear NOE (Supplementary Fig. 13) that are regarded as unique among the canonical triad of NMR relaxation parameters and essential for the identification of fast backbone motions. The other two relaxation parameters are longitudinal and transverse relaxation rates, R1 and R2, respectively (Supplementary Fig. 13a, b). 15N-(1H) NOE values become negative when extensive high-frequency (ps-ns) motions are present37. The observation agrees with the assertion that intrinsic disorder is often associated with protein flexibility38. It is interesting to note distinct changes in 15N-(1H) NOE values along loop L residues, moving from negative to positive near the h3 helix and then negative again (Supplementary Fig. 13c). Such a dynamic pattern matches with the “B”-shape tertiary structure of loop L (Fig. 2b), where the anchoring of h3 helix to the MA helix greatly reduces the frequency of motion of nearby residues and results in positive 15N-(1H) NOE values.

The inherent disorder and flexibility, as observed in the ICD, likely result from evolution. Long disordered regions exist in more than 30% of eukaryotic proteins39 and 70% of signaling proteins40. Disorder is not merely a structural defect. Conformational flexibility of disordered regions is probably required in mediating binding diversity to enable cellular signaling, regulation, and other functions41,42. Indeed, without a sufficient conformational flexibility, it is hard to imagine how the α7nAChR ICD could recruit and partner with a diverse group of intracellular proteins for various functions4,5,27,29,30. The same assessment is likely applicable to other Cys-loop receptors, whose ICDs may also contain flexible regions as loop L in the α7nAChR TMD + ICD structures, even though ICDs in this family of receptors have relatively low sequence homology (Supplementary Table 3). Future experiments are needed to reveal common and individualized ICD structural properties to guide the understanding of how individual receptors interact with diverse cytoplasmic proteins for different functions.

Despite being largely disordered, the ICD structure presents distinct features. The most noteworthy one is the anchoring of the h3 helix to the MA helix that divides loop L into two smaller loops with a shape of the letter B (Fig. 2). Typically, loop length and stability are inversely correlated24,43. Whether a shape of the letter B is a common architecture among ICDs of Cys-loop receptors will be interesting to determine. ICDs of other cation-conducting Cys-loop receptors typically have > 100 or even over 200 residues. Thus, the probability is high for having one anchoring point as occurred in the α7nAChR or even more anchoring points for a longer loop.

The α7nAChR ICD contains plenty of sequence and structure motifs for a wide range of functions (Fig. 4). Each motif may serve multiple functions. Take the α7nAChR MX helix as an example. In addition to its aforementioned functions4,27, the α7nAChR MX helix may directly interact with RIC-3, a chaperone protein that is known to promote α7nAChR assembly and trafficking44. A recent study shows that the mouse 5HT3A receptors’ MX helix binds human RIC-345. An unusually high sequence identity (~43%) in MX helices between the human α7nAChR and the mouse 5HT3A receptors (Supplementary Table 3) supports the prediction that the α7nAChR MX helix may also bind RIC-3.

The ICDs of Cys-loop receptors typically have lower sequence similarity, which makes it challenging to identify homologous domains and predict structures. Even within the nAChR family, different subtypes can have a drastically different ICD. For example, α7nAChR has 148 ICD residues but α4nAChR has 266 ICD residues (Supplementary Table 3). Their MX helices share only ~29% sequence identity, which is sufficiently low to differentiate their abilities to bind NMDA receptors and opens opportunities for α7nAChR-targeting therapeutics4. Indeed, it has been increasingly recognized6,46,47 that the divergency in the ICD, compared to the structural conservation of the ECD and TMD, provides greater potential for the development of receptor subtype-selective therapeutics, especially as more and more ICD structural information becomes available.

The success of structure determination of a full-length α7nAChR ICD sheds new light on an area that has been less explored thus far. NMR and ESR spectroscopy, in combination with Rosetta calculations, have provided an effective platform to obtain structural information for the flexible regions of the α7nAChR ICD. The approach used in the current study can be applied to solve ICD structures of other Cys-loop receptors or any structures of intrinsically flexible and disordered regions that cannot be determined by X-ray crystallography and cryo-EM. Notably, the flexible and disordered regions may experience significant conformational changes upon binding to their cellular targets and fold into ordered structures. Thus, the generation of α7nAChR TMD + ICD structures from the current study marks only the beginning of uncovering the mysteries of ICD structural arrangements in the absence and presence of binding partners. Much more is yet to be discovered for the structure-based understanding of signaling pathways mediated by the ICDs that can potentially benefit future structure-based drug discovery efforts targeting specific intracellular signaling.

## Methods

### Protein constructs, expression, and purification

Full-length human α7nAChR15 and TMD + ICD were produced in E. coli Rosetta 2(DE3) pLysS (Novagen). Expression constructs for the full-length human α7nAChR (UniProtKB P36544: ACHA7_HUMAN) and its cysteine mutants have been reported previously15,16. The TMD + ICD (Supplementary Fig. 1) was generated from the TMD construct17 by adding back the ICD using overlapping PCR and the primers shown in Supplementary Table 4. The constructs containing a single unpaired cysteine were generated as reported previously using the QuickChange Lightning Kit (Agilent Technologies), standard PCR protocols16, and confirmed by DNA sequencing. To obtain proteins for NMR, ESR, or binding studies, each construct was expressed in LB broth or M9 minimal media if isotopic labeling was required. Cells were grown at 37 °C until reaching an OD600 of 0.8 and then cultures were cooled to 15 °C before induction with 0.2 mM isopropyl β-D-thiogalatopyranoside (MilliporeSigma). For full-length α7nAChR, the induction media was supplemented with 0.5 M sorbitol, 10 mM MgCl2, and 10 mM choline. Proteins were expressed at 15 °C for ~16 h or ~72 h in LB or M9 media, respectively, and purified as described previously15 with the following modifications: cells harvested from 1 liter induction medium were suspended in 150 ml (TMD + ICD) or 600 ml (full-length α7nAChR) lysis buffer (50 mM Tris, pH 8, 500 mM NaCl, and HALT protease) and lysed using a Microfluidics M-110Y microfluidizer. The cell lysate was adjusted to 0.15% (w/v) dodecylphosphocholine (DPC, Anatrace) or 1% (w/v) lauryldimethylamine N-oxide (LDAO, MilliporeSigma) with 20 mM imidazole, incubated for 1 h, and then centrifuged at 20,000 × g for 20 min. The supernatant was incubated with 2 ml of NiNTA resin (GEHealthcare) for 1 h with gentle mixing. The resin was washed to a flat baseline with buffer at pH 8 containing 100 mM imidazole, 300 mM NaCl, 0.02 mg/ml asolectin (MilliporeSigma) with either 0.2% DPC or 0.4% LDAO, and the protein was eluted by adjusting the imidazole concentration to 300 mM. The pentamer fraction was isolated by size exclusion chromatography (SEC) using a S200 10/300 column (GEHealthcare) equilibrated with 20 mM HEPES pH 7.4, 300 mM NaCl, 0.2% DPC or 0.1% LDAO. Protein purity was confirmed by SDS-PAGE.

### Electrophysiology measurements

TEVC measurements of Xenopus oocytes injected with purified α7nAChR TMD + ICD (Fig. 1a) were performed as follows: 5 ng of the purified α7nAChR TMD + ICD reconstituted in asolectin liposomes was injected into Xenopus laevis oocytes (stages 5–6). After 1–2 days, channel function was measured in a 20 μl oocyte recording chamber (Automate Scientific) perfused at 2.4 ml/min and clamped at −60 mV with an OC-725C Amplifier (Warner Instruments). Recording solutions contained 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES at pH 7.0. Data were collected using Clampex 10.6 (Molecular Devices) and processed with Clampfit 10.6 (Molecular Devices). Nonlinear regressions and statistical analysis were performed using Prism software (GraphPad 7.04). The oocytes used in this study were kindly provided by Dr. Thomas Kleyman’s lab after harvesting from commercial female X. laevis (Xenopus 1, MI). All animal experimental procedures were approved by Institutional Animal Care and Use Committee (IACUC) of University Pittsburgh.

### Surface plasmon resonance

Steady-state surface plasmon resonance (SPR) responses to α7nAChR positive allosteric modulators (PAMs) (PNU-120596 and TQS) or protein (the PDZ domain of PICK1) binding (Supplementary Fig. 2d, e) were measured at 25 °C using a Biacore 3000 (version 4.1.2) with the NTA sensor chip (GE Healthcare, Uppsala, Sweden). α7nAChR was immobilized to the chip with densities between 1000 and 2000 RU. Responses to PAMs or PICK1 binding were acquired at a flow rate of 30 μl/min using Biacore 3000 acquisition software. After reference and buffer subtraction using BIAEvaluation 4.1.1, apparent dissociation constants were derived by non-linear regression analysis with GraphPad Prism 7.04 using a Langmuir isotherm equation for each PAM or protein-based on three independent injections for each concentration.

### Protein labeling, reconstitution, and sample preparations

MTSL labeling of unpaired single-cysteine full-length α7nAChR or the TMD + ICD α7nAChR followed the protocol published previously19,21. After buffer exchange to phosphate buffered saline (PBS) at pH 8 to remove the reducing agent DTT, a ~15- to 25-fold molar excess of the nitroxide spin label MTSL (Toronto Research Chemicals) was added to protein samples for ~2 h at room temperature, followed by incubation overnight at 4 °C to ensure labeling efficiency > 90%. Free MTSL was removed through dialysis, and then subjected to size exclusion chromatography (SEC) on a Superdex 200 10/300 column (GE Healthcare). For ESR, the purified protein at pH 8.0 was treated with only enough MTSL to achieve the desired 60–80% labeling, and any remaining unreacted MTSL was removed by SEC as described above before confirming the labeling efficiency by ESR.

For RDC NMR experiments, a lanthanide ion (paramagnetic: Tm3+ and Dy3+; diamagnetic: Lu3+) was incorporated into the single-cysteine α7nAChR TMD + ICD constructs using a thiol-specific disulfide reagent, N-[S-(2-pyridylthio)cysteaminyl]-EDTA (Toronto Research Chemicals), following published methods48. Briefly, a two-fold molar excess of LnCl3 (Sigma-Aldrich) was added to 10 mM N-[S-(2-pyridylthio)cysteaminyl]-EDTA in 100 mM Tris buffer at pH 7.3 and incubated for 1 h. After incubation, EDTA was added to the solution to adjust the free LnCl3 amount below a 5% excess and the solution was incubated for another 30 min. The TMD + ICD sample was treated with DTT in a 20-fold molar excess for 30 min. After removing DTT, the TMD + ICD sample in 50 mM Tris buffer at pH 8.0, 120 mM NaCl, and 0.5% LDAO was mixed with a 10-fold molar excess of N-[S-(2-pyridylthio)cysteaminyl]-EDTA-Ln3+ and incubated for 2 h. All reactions were done at room temperature in the dark. A desalting column was used to remove free small molecules from the protein sample.

The labeled α7nAChR in micelles were used either directly for NMR (Fig. 1c and Supplementary Figs. 3, 69, 13) or reconstituted in liposomes or nanodiscs for ESR (Supplementary Figs. 2c, 10) and selected NMR (Fig. 1c; Supplementary Figs. 3a–c) experiments. For protein reconstitution in liposomes, solubilized asolectin was added to purified protein in detergent at a 10-fold weight excess and gently agitated for 1 h before removing detergent using BioBeads. The liposomes were then collected by ultracentrifugation at 200,000 × g for 1 h, and resuspended by sonication (FB11207 FisherScientific) in PBS pH 7.4 prepared in D2O. For the preparation of styrene-maleic-acid (SMA) nanodiscs, the liposomes were solubilized with SMA (Xiran SL30010 P20, Polyscope Polymers BV) by adding 2× the weight of the asolectin present in the liposomes. For the preparation of membrane scaffold protein (MSP)-based nanodiscs, purified protein in detergent was mixed with solubilized asolectin lipids at a molar ratio of 80 lipids to one pentameric protein and mixed thoroughly for 30 min before adding the membrane scaffold protein MSP1D1 to the solution at a molar ratio of 2 (MSP1D1) to 80 (lipids). After incubating for 1 h, detergent was removed using Bio-Beads SM-2 Resin (Bio-Rad Laboratories) or Detergent Removal Resin (Thermo Scientific). A typical NMR sample (Fig. 1c; Supplementary Figs. 3, 69, 13) contained 0.2–0.3 mM protein in ~1 % LDAO micelles or in nanodiscs with 5 mM sodium acetate, pH 4.7, and 25 mM NaCl with 5% D2O for deuterium lock. A typical ESR sample contained 0.1–0.2 mM protein in nanodiscs or liposomes in phosphate-buffered saline pH 7.4 prepared in D2O (Supplementary Figs. 2c, 10).

### NMR spectroscopy for structure and dynamics determination

NMR spectra were recorded using TopSpin (versions 2.1 and 3.1–3.5, Bruker) on Bruker Avance 700–900 MHz spectrometers equipped with a triple-resonance inverse-detection TCI cryoprobe (Bruker Instruments), processed using NMRPipe49, and analyzed using OriginPro 8.5 (Origin Lab Corp) and Sparky50. In all NMR spectra, the 1H chemical shifts were referenced to the DSS resonance at 0 ppm and the 15N and 13C chemical shifts were referenced indirectly. A relaxation delay of 1 s was used in NMR data collection unless specified otherwise. The NMR experiments and most relevant acquisition parameters (Supplementary Table 5) are reported. The 1H, 15N, and 13C chemical shifts were assigned manually based on a suite of 3D spectra, including HNCA and HN(CO)CA with data points of 1024 × 36 × 72 and corresponding spectral windows of 12 × 23 × 28 ppm for the 1H, 15N, and 13C dimensions, respectively; HNCACB and CBCA(CO)NH (1024 × 36 × 104 points, 12 × 23 × 56 ppm); HNCO (1024 × 56 × 64 points, 12 × 23 × 12 ppm); and 15N or 13C-edited NOESY (1024 × 40 × 144 points, 13 × 23 × 13 ppm) with a mixing time of 200 ms (Supplementary Fig. 7). Backbone dihedral angle restraints and order parameters (Supplementary Fig. 5) were derived based on chemical shift of HN, Hα, Cα, Cβ, N using TALOS+51. 1H-15N TROSY-HSQC spectra were acquired at different temperatures (Supplementary Fig. 3) (25, 30, 35, 40, and 45 °C) to generate hydrogen-bonding restraints based on temperature coefficients of the backbone amide proton chemical shifts. Residues with coefficients <4.5 ppb/K were considered to have hydrogen bonding in helical regions52. To determine RDC NMR restraints, 1H-15N in-phase/anti-phase (IPAP) TROSY-HSQC spectra were recorded for the single-cysteine TMD + ICD constructs labeled with the paramagnetic N-[S-(2-pyridylthio)cysteaminyl]-EDTA-Tm3+/-Dy3+ or labeled with the diamagnetic N-[S-(2-pyridylthio)cysteaminyl]-EDTA-Lu3+. RDCs for individual resonances were obtained from the difference between the 15N chemical shifts in the in-phase and anti-phase spectra (Supplementary Fig. 6). To investigate the backbone dynamics of the TMD + ICD (Supplementary Fig. 13), NMR spectra for measuring 15N spin-lattice (R1) and spin-spin (R2) relaxation rates as well as 15N-(1H) heteronuclear Overhauser effects (hetNOEs) were collected. The spectra for R1 and R2 were acquired with a recycle delay of 3 s; variable delays (τ) ranging from 16–640 ms for R2 or 20–1500 ms for R1. 15N R1 and R2 relaxation rates and their uncertainties were obtained from the exponential fitting of NMR peak intensities versus the variable delays. The hetNOE spectra were collected with a recycle delay of 5 s. The hetNOE values were calculated as the ratios of peak intensities with and without proton saturation and the associated uncertainties were determined from the signal-to-noise ratio53. To derive distance restraints from PRE, 1H-15N TROSY-HSQC spectra were acquired on a group of single-cysteine TMD + ICD constructs labeled with MTSL (Supplementary Figs. 8, 9), and resulting in peak intensities in the paramagnetic (I) and diamagnetic (I0) conditions in the absence and presence of a ~10-fold excess of ascorbic acid. The intensity ratio (I/I0) and diamagnetic peak linewidth were used to determine the paramagnetic enhancement of the transverse relaxation rate R2sp, which was used for deriving distances between the MTSL paramagnetic nitroxide and amid proton of individual residues using the Solomon and Bloembergen equation as described previously54,55.

### ESR spectroscopy

To measure labeling efficiency, continuous wave (CW) ESR spectra were collected using Xepr 2.6b.176 on a Bruker ElexSys E680 CW/FT X-band spectrometer equipped with a Bruker ER4122 SHQE-W1 high-resolution resonator at 291 ± 1 K. The parameters for each spin-labeled CW spectrum include a center field of 3514 G and sweep width of 150 G, modulation amplitude of 1 G, modulation frequency of 100 kHz, conversion time of 20.48 ms, and 1024 data points. The doubly integrated intensity of the CW spectrum was compared to a calibration point for quantifying the nitroxide concentration and ultimately the labeling efficiency.

Four pulse DEER experiments were performed on either a Bruker ElexSys E680 CW/FT X-band spectrometer equipped with a Bruker EN4118X-MD4 resonator or Bruker ElexSys E580 Q-band CW/FT spectrometer using an ER 5106-QT2 resonator. All DEER samples were prepared at a spin concentration of 60–160 μM with deuterated glycerol (20% v/v) as a cryoprotectant, and flash frozen in 3 mm I.D. or 2 mm I.D. Pyrex capillary for X-band or Q-band, respectively. DEER experiments followed the pulse sequence [(π/2)ν1 - τ1 - (π)ν1 - t+dt - (π)ν2 - τ2 - (π)ν1 - τ2 – echo]56. The pump frequency (ν2) was set 70 MHz up-field from the observer frequency (ν1). The observe (π)ν1 pulse length and pump (π)ν2 pulse length, pump pulse step size (dt), and number of data points (n) are optimized for individual samples with τ1 of 400 ns and τ2 being slightly larger than n*dt. The time domain DEER signal was analyzed with DD57.

### Structure calculations in rosetta

Structure calculations used the comparative modeling protocol (RosettaCM)58 in Rosetta 3.759 with the talaris2014 energy function60. The resource of Open Science Grid61 was used for the Rosetta structural calculations. Four major components (Supplementary Fig. 4) are included in iterative calculations. Component 1 (Supplementary Fig. 4a) integrated various experimental restraints (Supplementary Table 1) into RosettaCM, for which fragment libraries were generated using CS-Rosetta18 on the Robetta server62 with input chemical shifts, RDC, and NOE data. Other structure restraints (hydrogen bonds, NOE and PRE, and DEER distance restraints) and the five-fold symmetry were used to restrict the conformational space and improve protein folding. Two template structures from 5-HT3 receptors (PDBID: 6BE1 and 4PIR)8,35 were only used in the first round of iterative calculations. Component 2 utilized the input from Component 1 to perform an iterative folding protocol (Supplementary Fig. 4b), which guided conformational sampling towards the global energy minimum while maintaining structural diversity to ensure that calculations did not become trapped in local energy minima. 1,000 structures were generated in each iteration of folding (ICD or later TMD + ICD) with the experimental restraints specified by our experiments. Output structures from each round were ranked by a total score Stotal, a sum of the standard weighted physics-based (Sphysics) and knowledge-based (Sknowledge) potentials from the talaris2014 energy function60, and the harmonic (SDEER) and sigmoid (SPRE) restraint potentials. The top 100 structures were clustered with a 3 Å RMSD cutoff63 using Matlab 2020b (Mathworks) and the top ranked structures from each cluster were input as new template structures for the next iteration of folding calculations. Folding of the ICD and the TMD + ICD converged after 6 and 16 rounds, respectively (Supplementary Fig. 4e, f). Component 3 was for refinement of the TMD + ICD structures (Supplementary Fig. 4c) that began with Rosetta FastRelax64, consisting of several cycles of packing and all-atom minimization. The top 50 structures from the last cycle were selected for discrete MD simulations in Chiron65 to minimize steric clashes, followed by geometry optimization using Phenix 1.1966. Finally, in Component 4 (Supplementary Fig. 4d), the structures were validated by the Q-factor67 (analogous to the crystallographic R-factor) as defined in Eq. 1 using Matlab 2020b (Mathworks):

$$Q={\sqrt{\frac{\sum_i \left(r_{{{{{{\mathrm{exp}}}}}}}\left(i\right) -r_{{{{{{\mathrm{calc}}}}}}} \left(i\right)\right)^{2}} {\sum_i {r}_{{{{{{\mathrm{exp}}}}}}}\left(i\right)^{2} }}}$$
(1)

where rexp is the experimental restraint distance and rcalc is the distance observed in the calculated structure. Q-factors evaluated agreement between calculated and experimental distances and were calculated separately for ESR DEER restraints (QDEER) and for NMR NOE (QNOE) and PRE (QPRE) (Supplementary Table 2). In addition, QPREfree was calculated using 56 PRE restraints (~10% of total PRE restraints) that were excluded in structure calculations. Other parameters characterizing the quality of the final structures were evaluated using MolProbity68 and Phenix66 1.19 (Supplementary Table 2). VMD69 was used for structure rendering, visualization, and analysis. Pore profiles were calculated using the HOLE program70.

### Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

## Data availability

The atomic coordinates and structural restraints for 15 structures of the apo α7nAChR TMD + ICD have been deposited in the Protein Data Bank with the accession code 7RPM. The chemical shift values have been deposited in the Biological Magnetic Resonance Data Bank (BMRB), accession number BMR30939. The source data underlying Figs. 1, 2, 5 and Supplementary Figs. 2, 4, 5, 8, 10, 13, 15 are provided as a Source Data file. Other data that support the findings of this study are available upon reasonable request to the corresponding author. Source data are provided with this paper.

## References

1. Kracun, S., Harkness, P. C., Gibb, A. J. & Millar, N. S. Influence of the M3-M4 intracellular domain upon nicotinic acetylcholine receptor assembly, targeting and function. Br. J. Pharmacol. 153, 1474–1484 (2008).

2. Castelan, F. et al. Cytoplasmic regions adjacent to the M3 and M4 transmembrane segments influence expression and function of alpha7 nicotinic acetylcholine receptors. A study with single amino acid mutants. J. Neurochem. 100, 406–415 (2007).

3. Ivica, J. et al. The intracellular domain of homomeric glycine receptors modulates agonist efficacy. J. Biol. Chem. 296, 100387 (2021).

4. Li, S., Li, Z., Pei, L., Le, A. D. & Liu, F. The alpha7nACh-NMDA receptor complex is involved in cue-induced reinstatement of nicotine seeking. J. Exp. Med. 209, 2141–2147 (2012).

5. King, J. R., Nordman, J. C., Bridges, S. P., Lin, M. K. & Kabbani, N. Identification and characterization of a G protein-binding cluster in alpha7 nicotinic acetylcholine receptors. J. Biol. Chem. 290, 20060–20070 (2015).

6. Stokes, C., Treinin, M. & Papke, R. L. Looking below the surface of nicotinic acetylcholine receptors. Trends Pharmacol. Sci. 36, 514–523 (2015).

7. Noviello C. M. et al. Structure and gating mechanism of the alpha7 nicotinic acetylcholine receptor. Cell 184, 2121–2134.e13 (2021).

8. Basak, S. et al. Cryo-EM structure of 5-HT3A receptor in its resting conformation. Nat. Commun. 9, 514 (2018).

9. Polovinkin, L. et al. Conformational transitions of the serotonin 5-HT3 receptor. Nature 563, 275–279 (2018).

10. Jumper J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).

11. Baek M. et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science 373, 871–876 (2021).

12. Dyson, H. J. & Wright, P. E. Unfolded proteins and protein folding studied by NMR. Chem. Rev. 104, 3607–3622 (2004).

13. Taly, A., Corringer, P. J., Guedin, D., Lestage, P. & Changeux, J. P. Nicotinic receptors: Allosteric transitions and therapeutic targets in the nervous system. Nat. Rev. Drug Discov. 8, 733–750 (2009).

14. Alsharari, S. D., Freitas, K. & Damaj, M. I. Functional role of alpha7 nicotinic receptor in chronic neuropathic and inflammatory pain: studies in transgenic mice. Biochem. Pharmacol. 86, 1201–1207 (2013).

15. Tillman, T. S. et al. Functional human alpha7 nicotinic acetylcholine receptor (nAChR) generated from Escherichia coli. J. Biol. Chem. 291, 18276–18282 (2016).

16. Tillman, T. S., Choi, Z., Xu, Y. & Tang, P. Functional tolerance to cysteine mutations in human alpha7 nicotinic acetylcholine receptors. ACS Chem. Neurosci. 11, 242–247 (2020).

17. Bondarenko, V. et al. NMR structures of the human alpha7 nAChR transmembrane domain and associated anesthetic binding sites. Biochim. Biophys. Acta 1838, 1389–1395 (2014).

18. Shen, Y. et al. Consistent blind protein structure generation from NMR chemical shift data. Proc. Natl Acad. Sci. USA 105, 4685–4690 (2008).

19. Bondarenko, V. et al. (19)F paramagnetic relaxation-based NMR for quaternary structural restraints of ion channels. ACS Chem. Biol. 14, 2160–2165 (2019).

20. Olivieri, C. et al. Simultaneous detection of intra- and inter-molecular paramagnetic relaxation enhancements in protein complexes. J. Biomol. NMR 70, 133–140 (2018).

21. Kinde, M. N. et al. Conformational changes underlying desensitization of the pentameric ligand-gated ion channel ELIC. Structure 23, 995–1004 (2015).

22. Ovchinnikov, S. et al. Protein structure determination using metagenome sequence data. Science 355, 294–298 (2017).

23. Zhao, Y. et al. Structural basis of human alpha7 nicotinic acetylcholine receptor activation. Cell Res. 31, 713–716 (2021).

24. Nagi, A. D. & Regan, L. An inverse correlation between loop length and stability in a four-helix-bundle protein. Fold. Des. 2, 67–75 (1997).

25. Jeffrey G. A. An Introduction to Hydrogen Bonding (Oxford University Press, 1997).

26. Rawat, N. & Biswas, P. Hydrogen bond dynamics in intrinsically disordered proteins. J. Phys. Chem. B 118, 3018–3025 (2014).

27. Kumar, M. et al. ELM-the eukaryotic linear motif resource in 2020. Nucleic Acids Res. 48, D296–D306 (2020).

28. Moreira, I. S. Structural features of the G-protein/GPCR interactions. Biochim. Biophys. Acta 1840, 16–33 (2014).

29. Xu, J., Zhu, Y. & Heinemann, S. F. Identification of sequence motifs that target neuronal nicotinic receptors to dendrites and axons. J. Neurosci. 26, 9780–9793 (2006).

30. Margeta, M. A., Wang, G. J. & Shen, K. Clathrin adaptor AP-1 complex excludes multiple postsynaptic receptors from axons in C. elegans. Proc. Natl Acad. Sci. USA 106, 1632–1637 (2009).

31. Russ, W. P. & Engelman, D. M. The GxxxG motif: a framework for transmembrane helix–helix association. J. Mol. Biol. 296, 911–919 (2000).

32. Kay, B. K., Williamson, M. P. & Sudol, M. The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14, 231–241 (2000).

33. Dyson, H. J. & Wright, P. E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6, 197–208 (2005).

34. Pan, J. et al. Structure of the pentameric ligand-gated ion channel ELIC cocrystallized with its competitive antagonist acetylcholine. Nat. Commun. 3, 714 (2012).

35. Hassaine, G. et al. X-ray structure of the mouse serotonin 5-HT3 receptor. Nature 512, 276–281 (2014).

36. Minezaki, Y., Homma, K. & Nishikawa, K. Intrinsically disordered regions of human plasma membrane proteins preferentially occur in the cytoplasmic segment. J. Mol. Biol. 368, 902–913 (2007).

37. Jarymowycz, V. A. & Stone, M. J. Fast time scale dynamics of protein backbones: NMR relaxation methods, applications, and functional consequences. Chem. Rev. 106, 1624–1671 (2006).

38. Radivojac, P. et al. Protein flexibility and intrinsic disorder. Protein Sci. 13, 71–80 (2004).

39. Ward, J. J., Sodhi, J. S., McGuffin, L. J., Buxton, B. F. & Jones, D. T. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J. Mol. Biol. 337, 635–645 (2004).

40. Iakoucheva, L. M., Brown, C. J., Lawson, J. D., Obradovic, Z. & Dunker, A. K. Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 323, 573–584 (2002).

41. Seiffert, P. et al. Orchestration of signaling by structural disorder in class 1 cytokine receptors. Cell Commun. Signal 18, 132 (2020).

42. Wright, P. E. & Dyson, H. J. Intrinsically disordered proteins in cellular signalling and regulation. Nat. Rev. Mol. Cell Biol. 16, 18–29 (2015).

43. Martin, A. C., Toda, K., Stirk, H. J. & Thornton, J. M. Long loops in proteins. Protein Eng. 8, 1093–1101 (1995).

44. Alexander, J. K. et al. Ric-3 promotes alpha7 nicotinic receptor assembly and trafficking through the ER subcompartment of dendrites. J. Neurosci. 30, 10112–10126 (2010).

45. Pirayesh, E., Stuebler, A. G., Pandhare, A. & Jansen, M. Delineating the site of interaction of the 5-HT3A receptor with the chaperone protein RIC-3. Biophys. J. 118, 934–943 (2020).

46. Li, J. et al. Artemisinins target GABAA receptor signaling and impair alpha cell identity. Cell 168, 86–100 e115 (2017).

47. Guzman, L. et al. Blockade of ethanol-induced potentiation of glycine receptors by a peptide that interferes with Gbetagamma binding. J. Pharmacol. Exp. Ther. 331, 933–939 (2009).

48. Kamen, D. E., Cahill, S. M. & Girvin, M. E. Multiple alignment of membrane proteins for measuring residual dipolar couplings using lanthanide ions bound to a small metal chelator. J. Am. Chem. Soc. 129, 1846–1847 (2007).

49. Delaglio, F. et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).

50. Goddard, T. & Kneller, D. Sparky 3 NMR Software (University of California, 2001).

51. Shen, Y., Delaglio, F., Cornilescu, G. & Bax, A. TALOS+: A hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J. Biomol. NMR 44, 213–223 (2009).

52. Baxter, N. J. & Williamson, M. P. Temperature dependence of H-1 chemical shifts in proteins. J. Biomol. NMR 9, 359–369 (1997).

53. Farrow, N. A. et al. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry 33, 5984–6003 (1994).

54. Solomon, I. & Bloembergen, N. Nuclear magnetic interactions in the Hf molecule. J. Chem. Phys. 25, 261–266 (1956).

55. Battiste, J. L. & Wagner, G. Utilization of site-directed spin labeling and high-resolution heteronuclear nuclear magnetic resonance for global fold determination of large proteins with limited nuclear overhauser effect data. Biochemistry 39, 5355–5365 (2000).

56. Pannier, M., Veit, S., Godt, A., Jeschke, G. & Spiess, H. W. Dead-time free measurement of dipole-dipole interactions between electron spins. J. Magn. Reson. 142, 331–340 (2000).

57. Stein, R. A., Beth, A. H. & Hustedt, E. J. A straightforward approach to the analysis of double electron-electron resonance data. Methods Enzymol. 563, 531–567 (2015).

58. Song, Y. et al. High-resolution comparative modeling with RosettaCM. Structure 21, 1735–1742 (2013).

59. Leaver-Fay, A. et al. ROSETTA3: An object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol. 487, 545–574 (2011).

60. Leaver-Fay, A. et al. Scientific benchmarks for guiding macromolecular energy function improvement. Methods Enzymol. 523, 109–143 (2013).

61. Pordes, R. et al. The open science grid. J. Phys. Conf. Ser. 78, 012057 (2007).

62. Kim, D. E., Chivian, D. & Baker, D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 32, W526–W531 (2004).

63. Bender, B. J. et al. Protocols for molecular modeling with Rosetta3 and RosettaScripts. Biochemistry 55, 4748–4763 (2016).

64. Tyka, M. D. et al. Alternate states of proteins revealed by detailed energy landscape mapping. J. Mol. Biol. 405, 607–618 (2011).

65. Ramachandran, S., Kota, P., Ding, F. & Dokholyan, N. V. Automated minimization of steric clashes in protein structures. Proteins 79, 261–270 (2011).

66. Adams, P. D. et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213–221 (2010).

67. Iwahara, J., Schwieters, C. D. & Clore, G. M. Ensemble approach for NMR structure refinement against (1)H paramagnetic relaxation enhancement data arising from a flexible paramagnetic group attached to a macromolecule. J. Am. Chem. Soc. 126, 5879–5896 (2004).

68. Chen, V. B. et al. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66, 12–21 (2010).

69. Humphrey, W., Dalke, A. & Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph 14, 27–38 (1996). 33-38.

70. Smart, O. S., Neduvelil, J. G., Wang, X., Wallace, B. A. & Sansom, M. S. HOLE: A program for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph 14, 354–360 (1996).

## Acknowledgements

The authors thank Drs. Özge Yoluk and Frank DiMaio for their help in initial Rosetta structure calculations, Dr. Monica Kinde, Mr. Michel Guerrero Tenorio, and Dr. Rieko Ishima for their help in sample preparation and characterizations. Mass spectrometry analysis used the University of Pittsburgh Cancer Institute Cancer Biomarkers Facility that is supported in part by NIH grant P30CA047904. The structural calculations were performed using computational resources provided by the Open Science Grid, which is supported by the National Science Foundation award 1148698, and the U.S. Department of Energy’s Office of Science. The reported research was supported by the National Institute on Drug Abuse (NIDA) of the US National Institutes of Health (NIH) under grant Awards Number R01DA046939 (to P.T.). M.M.W. and J.C. were supported by NIH training grants T32EB009403 and T32GM075770, respectively.

## Author information

Authors

### Contributions

V.B. performed NMR experiments; V.B., M.M.W., Q.C., J.C., and N.B. analyzed NMR data. V.B., M.M.W., and Q.C. performed structure calculations. T.S.T. made protein constructs and performed functional and pharmacological characterizations of the constructs; K.S. and M.J.L. performed ESR experiments and data analysis with the advice from S.S. J.A.C. performed negative-stain imaging. P.T. along with Y.X. and E.L. initiated and designed the project. P.T. wrote the manuscript with input from E.L., Y.X., and other authors. All authors reviewed the results and approved the final version of the manuscript.

### Corresponding author

Correspondence to Pei Tang.

## Ethics declarations

### Competing interests

The authors declare no competing interests.

## Peer review

### Peer review information

Nature Communications thanks James Chou, Chris Ulens, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

## Rights and permissions

Reprints and Permissions

Bondarenko, V., Wells, M.M., Chen, Q. et al. Structures of highly flexible intracellular domain of human α7 nicotinic acetylcholine receptor. Nat Commun 13, 793 (2022). https://doi.org/10.1038/s41467-022-28400-x

• Accepted:

• Published:

• DOI: https://doi.org/10.1038/s41467-022-28400-x